• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示他汀类药物的抗菌特性:一项关于……的研究

Unveiling the Antibacterial Properties of Statins: An Study on .

作者信息

Ebrahimzadeh Manijeh, Asgharpour Fariba, Shokri Shirvani Javad, Kazemi Sohrab, Moghadamnia Ali Akbar

机构信息

Student Research Committee Health Research Institute Babol University of Medical Sciences, Babol, Iran.

Department of Laboratory Sciences Faculty of Para-Medicine Babol University of Medical Sciences, Babol, Iran.

出版信息

Adv Pharmacol Pharm Sci. 2024 Aug 12;2024:6380155. doi: 10.1155/2024/6380155. eCollection 2024.

DOI:10.1155/2024/6380155
PMID:39161645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11333129/
Abstract

BACKGROUND

(), a widespread bacterial pathogen, is associated with various gastrointestinal diseases, including gastric cancer. Statins, widely prescribed cholesterol-lowering agents, have demonstrated pleiotropic effects, including potential antimicrobial properties. This study investigated the direct antibacterial effects of three clinically approved statins, simvastatin, atorvastatin, and rosuvastatin, against isolates.

METHODS

strains were isolated from gastric biopsies of dyspeptic patients and identified by microbiological techniques. The minimum inhibitory concentrations (MICs) of statins were determined using the agar dilution method, and their antimicrobial activity was evaluated by the disc diffusion method using different concentrations of simvastatin, atorvastatin, rosuvastatin, tetracycline, and amoxicillin. Scanning electron microscopy (SEM) was employed to examine the morphology of cells.

RESULTS

The minimum inhibitory concentration (MIC) values (g/mL) of atorvastatin, rosuvastatin, simvastatin, tetracycline, and amoxicillin against were 240 ± 20, 450 ± 20, 460 ± 15, 155 ± 30, and 140 ± 20, respectively. In the disc diffusion assay, atorvastatin and rosuvastatin produced significantly larger inhibition zones compared to simvastatin at all concentrations tested ( < 0.05). The inhibition zone diameters (mm) increased with higher statin concentrations, ranging from 9 ± 1.4 to 13 ± 1.4 for atorvastatin, 8 ± 0.9 to 11 ± 0.6 for rosuvastatin, and 5 ± 1.3 to 6 ± 1.4 for simvastatin at the highest tested concentration (1200 g/ml). SEM analysis revealed the characteristic spiral morphology of cells.

CONCLUSION

Statins demonstrated varying degrees of antibacterial activity against isolates, with atorvastatin exhibiting the highest potency. While the observed effects were lower than those of conventional antibiotics, these findings suggest the potential of statins as adjunctive agents or alternative therapeutic options, warranting further investigation through studies and clinical trials.

摘要

背景

()是一种广泛传播的细菌病原体,与包括胃癌在内的多种胃肠道疾病有关。他汀类药物是广泛使用的降胆固醇药物,已显示出多效性作用,包括潜在的抗菌特性。本研究调查了三种临床批准的他汀类药物,辛伐他汀、阿托伐他汀和瑞舒伐他汀,对分离株的直接抗菌作用。

方法

从消化不良患者的胃活检组织中分离出菌株,并通过微生物学技术进行鉴定。使用琼脂稀释法测定他汀类药物的最低抑菌浓度(MIC),并使用不同浓度的辛伐他汀、阿托伐他汀、瑞舒伐他汀、四环素和阿莫西林,通过纸片扩散法评估它们的抗菌活性。采用扫描电子显微镜(SEM)检查细胞的形态。

结果

阿托伐他汀、瑞舒伐他汀、辛伐他汀、四环素和阿莫西林对的最低抑菌浓度(MIC)值(μg/mL)分别为240±20、450±20、460±15、155±30和140±20。在纸片扩散试验中,在所有测试浓度下,阿托伐他汀和瑞舒伐他汀产生的抑菌圈明显大于辛伐他汀(P<0.05)。抑菌圈直径(mm)随着他汀类药物浓度的升高而增加,在最高测试浓度(1200μg/ml)下,阿托伐他汀的抑菌圈直径从9±1.4增加到13±1.4,瑞舒伐他汀从8±0.9增加到11±0.6,辛伐他汀从5±1.3增加到6±1.4。SEM分析显示了细胞的特征性螺旋形态。

结论

他汀类药物对分离株表现出不同程度的抗菌活性,阿托伐他汀的效力最高。虽然观察到的效果低于传统抗生素,但这些发现表明他汀类药物作为辅助剂或替代治疗选择的潜力,值得通过进一步的研究和临床试验进行深入调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/b7e809ef9c85/APS2024-6380155.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/e53597eac839/APS2024-6380155.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/10b46625a0c3/APS2024-6380155.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/b7e809ef9c85/APS2024-6380155.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/e53597eac839/APS2024-6380155.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/10b46625a0c3/APS2024-6380155.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e3/11333129/b7e809ef9c85/APS2024-6380155.003.jpg

相似文献

1
Unveiling the Antibacterial Properties of Statins: An Study on .揭示他汀类药物的抗菌特性:一项关于……的研究
Adv Pharmacol Pharm Sci. 2024 Aug 12;2024:6380155. doi: 10.1155/2024/6380155. eCollection 2024.
2
An In Vitro Study on the Antibacterial Activity of Statins Against the Most Common Bacterial Pathogens Causing Respiratory Tract Infections in a Tertiary Care Hospital.一项关于他汀类药物对某三级护理医院中引起呼吸道感染的最常见细菌病原体抗菌活性的体外研究。
Cureus. 2024 Apr 12;16(4):e58108. doi: 10.7759/cureus.58108. eCollection 2024 Apr.
3
Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.他汀类药物的抗菌活性:阿托伐他汀、辛伐他汀和瑞舒伐他汀的比较研究。
Ann Clin Microbiol Antimicrob. 2012 May 7;11:13. doi: 10.1186/1476-0711-11-13.
4
Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin.他汀类药物对肝癌细胞的一些多效作用:阿托伐他汀、瑞舒伐他汀和辛伐他汀的对比研究。
Adv Med Sci. 2023 Sep;68(2):258-264. doi: 10.1016/j.advms.2023.07.002. Epub 2023 Jul 19.
5
Statins: antimicrobial resistance breakers or makers?他汀类药物:是抗微生物耐药性的破坏者还是制造者?
PeerJ. 2017 Oct 24;5:e3952. doi: 10.7717/peerj.3952. eCollection 2017.
6
Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.评估同时接受强 P 糖蛋白抑制剂和他汀类药物治疗的患者的抗 Xa 活性。
J Clin Pharm Ther. 2022 May;47(5):668-675. doi: 10.1111/jcpt.13596. Epub 2022 Jan 15.
7
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.与他汀类单药治疗滴定相比,依折麦布联合辛伐他汀、阿托伐他汀或瑞舒伐他汀治疗时低密度脂蛋白胆固醇(LDL-C)水平的变化及目标达成情况。
Vasc Health Risk Manag. 2013;9:719-27. doi: 10.2147/VHRM.S49840. Epub 2013 Nov 15.
8
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.台湾幽门螺杆菌分离株的体外比较抗菌药敏试验和抗菌联合用药的协同活性。
J Microbiol Immunol Infect. 2015 Feb;48(1):72-9. doi: 10.1016/j.jmii.2012.08.021. Epub 2012 Oct 1.
9
Consumption of non-antibacterial drugs may have negative impact on colonization in the stomach.非抗菌药物的使用可能会对胃部的细菌定植产生负面影响。
Heliyon. 2024 Mar 4;10(5):e27327. doi: 10.1016/j.heliyon.2024.e27327. eCollection 2024 Mar 15.
10
Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome.瑞舒伐他汀与阿托伐他汀、普伐他汀和辛伐他汀在伴有或不伴有代谢综合征的血脂异常糖尿病患者中的成本效益、安全性及疗效比较
J Prim Care Community Health. 2014 Jul;5(3):180-7. doi: 10.1177/2150131914520991. Epub 2014 Feb 11.

本文引用的文献

1
Detection and Treatment of : Problems and Advances.检测与治疗:问题与进展
Gastroenterol Res Pract. 2022 Oct 22;2022:4710964. doi: 10.1155/2022/4710964. eCollection 2022.
2
Factors Affecting the Intraluminal Therapy for Infection.影响腔内感染治疗的因素。
Microorganisms. 2022 Feb 11;10(2):415. doi: 10.3390/microorganisms10020415.
3
Clinical Factors Implicated in Antibiotic Resistance in Patients.患者抗生素耐药性相关的临床因素
Microorganisms. 2022 Jan 29;10(2):322. doi: 10.3390/microorganisms10020322.
4
Epidemiology of Helicobacter pylori.幽门螺杆菌流行病学。
Aliment Pharmacol Ther. 2022 Jan;55 Suppl 1:S1-S13. doi: 10.1111/apt.16592.
5
Pleiotropic Effects of Statins: New Therapeutic Approaches to Chronic, Recurrent Infection by .他汀类药物的多效性:针对……引起的慢性复发性感染的新治疗方法
Pharmaceutics. 2021 Nov 30;13(12):2047. doi: 10.3390/pharmaceutics13122047.
6
Statins' Regulation of the Virulence Factors of and the Production of ROS May Inhibit the Development of Gastric Cancer.他汀类药物对毒力因子的调节及活性氧的产生可能抑制胃癌的发展。
Antioxidants (Basel). 2021 Aug 16;10(8):1293. doi: 10.3390/antiox10081293.
7
Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses.他汀类药物与心血管疾病一级预防中不良事件的相关性:系统评价、网络荟萃分析和剂量反应荟萃分析。
BMJ. 2021 Jul 14;374:n1537. doi: 10.1136/bmj.n1537.
8
Multidrug resistance: The clinical dilemma of refractory Helicobacter pylori infection.多药耐药性:难治性幽门螺杆菌感染的临床困境。
J Microbiol Immunol Infect. 2021 Dec;54(6):1184-1187. doi: 10.1016/j.jmii.2021.03.006. Epub 2021 Mar 23.
9
Extra-Gastric Manifestations of Infection.感染的胃外表现
J Clin Med. 2020 Nov 30;9(12):3887. doi: 10.3390/jcm9123887.
10
Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated Infection: A Territory-Wide Propensity Score Matched Study.他汀类药物与根除 感染患者的胃癌风险降低相关:一项全港范围的倾向评分匹配研究。
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):493-499. doi: 10.1158/1055-9965.EPI-19-1044. Epub 2019 Dec 2.